All cause adverse events ≥10% (all grade) or grade ≥3 in 2 or more patients
. | N = 22, n (%) . | |
---|---|---|
All grade AEs . | Grade ≥3 AEs* . | |
Any AE | 22 (100) | 12 (55) |
Fatigue | 20 (91) | 2 (9) |
Diarrhea | 16 (73) | – |
Nausea | 15 (68) | – |
Anemia | 11 (50) | 7 (32) |
Fever | 10 (45) | – |
Constipation | 9 (41) | – |
Leukopenia | 8 (36) | – |
Thrombocytopenia | 8 (36) | 2 (9) |
Vomiting | 8 (36) | 2 (9) |
Anorexia | 8 (36) | 1 (5) |
Cough | 8 (36) | – |
Chills | 7 (31) | – |
Hypocalcemia | 6 (27) | – |
Neutropenia | 5 (22) | 2 (9) |
Respiratory infection | 5 (22) | 2 (9) |
Dehydration | 5 (22) | 2 (9) |
Hypotension | 5 (22) | 1 (5) |
Weight loss | 5 (22) | 1 (5) |
Abdominal pain | 5 (22) | – |
Headache | 5 (22) | – |
Dyspnea | 4 (18) | 2 (9) |
Creatinine increase | 4 (18) | 1 (5) |
Dysgeusia | 4 (18) | – |
Malaise | 4 (18) | – |
Hypoalbuminemia | 4 (18) | – |
Peripheral edema | 4 (18) | – |
Muscle weakness | 3 (13) | 2 (9) |
Rash | 3 (13) | 1 (5) |
Insomnia | 3 (13) | – |
Paresthesia | 3 (13) | – |
Oral dysesthesia | 3 (13) | – |
ALT increase | 3 (13) | – |
Back pain | 3 (13) | – |
Sepsis | 2 (9) | 2 (9) |
. | N = 22, n (%) . | |
---|---|---|
All grade AEs . | Grade ≥3 AEs* . | |
Any AE | 22 (100) | 12 (55) |
Fatigue | 20 (91) | 2 (9) |
Diarrhea | 16 (73) | – |
Nausea | 15 (68) | – |
Anemia | 11 (50) | 7 (32) |
Fever | 10 (45) | – |
Constipation | 9 (41) | – |
Leukopenia | 8 (36) | – |
Thrombocytopenia | 8 (36) | 2 (9) |
Vomiting | 8 (36) | 2 (9) |
Anorexia | 8 (36) | 1 (5) |
Cough | 8 (36) | – |
Chills | 7 (31) | – |
Hypocalcemia | 6 (27) | – |
Neutropenia | 5 (22) | 2 (9) |
Respiratory infection | 5 (22) | 2 (9) |
Dehydration | 5 (22) | 2 (9) |
Hypotension | 5 (22) | 1 (5) |
Weight loss | 5 (22) | 1 (5) |
Abdominal pain | 5 (22) | – |
Headache | 5 (22) | – |
Dyspnea | 4 (18) | 2 (9) |
Creatinine increase | 4 (18) | 1 (5) |
Dysgeusia | 4 (18) | – |
Malaise | 4 (18) | – |
Hypoalbuminemia | 4 (18) | – |
Peripheral edema | 4 (18) | – |
Muscle weakness | 3 (13) | 2 (9) |
Rash | 3 (13) | 1 (5) |
Insomnia | 3 (13) | – |
Paresthesia | 3 (13) | – |
Oral dysesthesia | 3 (13) | – |
ALT increase | 3 (13) | – |
Back pain | 3 (13) | – |
Sepsis | 2 (9) | 2 (9) |
Grade ≥3 AEs occurring in 1 patient each (5%) and not mentioned above were: urinary tract infection, cellulitis, transient ischemic attack, pleural effusion, hypoxia, hypokalemia, and hyperuricemia.
AE, adverse event; ALT, alanine transaminase; –, 0 patients.